From January 1, 2024 to March 31, 2024, the company has repurchased 312,170 shares, representing 0.29% for $298.09 million. With this, the company has completed the repurchase of 2,253,328 shares, representing 2.11% for $1,769.01 million under the buyback announced on February 3, 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
990.3 USD | +1.00% | +0.70% | +12.63% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.63% | 106B | |
+12.11% | 116B | |
-9.78% | 23.89B | |
-1.69% | 21.58B | |
-10.60% | 18.96B | |
-41.25% | 16.96B | |
-14.75% | 16.33B | |
+6.22% | 14.14B | |
+29.53% | 12.02B | |
-2.10% | 7.58B |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Tranche Update on Regeneron Pharmaceuticals, Inc.'s Equity Buyback Plan announced on February 3, 2023.